Genolution Financial Statements From 2010 to 2024

225220 Stock  KRW 2,240  105.00  4.48%   
Genolution financial statements provide useful quarterly and yearly information to potential Genolution investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Genolution financial statements helps investors assess Genolution's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Genolution's valuation are summarized below:
Genolution does not presently have any fundamental trends for analysis.
Check Genolution financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genolution's main balance sheet or income statement drivers, such as , as well as many indicators such as . Genolution financial statements analysis is a perfect complement when working with Genolution Valuation or Volatility modules.
  
This module can also supplement various Genolution Technical models . Check out the analysis of Genolution Correlation against competitors.

Genolution Company Shares Owned By Insiders Analysis

Genolution's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Genolution Shares Owned By Insiders

    
  25.54 %  
Most of Genolution's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genolution is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition
Based on the latest financial disclosure, 25.536% of Genolution are shares owned by insiders. This is much higher than that of the sector and significantly higher than that of the Biotechnology & Medical Research industry. The shares owned by insiders for all Republic of Korea stocks is notably lower than that of the firm.

Genolution Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Genolution's current stock value. Our valuation model uses many indicators to compare Genolution value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genolution competition to find correlations between indicators driving Genolution's intrinsic value. More Info.
Genolution is number one stock in return on equity category among its peers. It also is number one stock in profit margin category among its peers fabricating about  0.02  of Profit Margin per Return On Equity. The ratio of Return On Equity to Profit Margin for Genolution is roughly  62.77 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Genolution by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genolution's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Genolution Financial Statements

Genolution stakeholders use historical fundamental indicators, such as Genolution's revenue or net income, to determine how well the company is positioned to perform in the future. Although Genolution investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genolution's assets and liabilities are reflected in the revenues and expenses on Genolution's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genolution. Please read more on our technical analysis and fundamental analysis pages.
Genolution Inc. manufactures and sells IVD products in South Korea and internationally. The company was founded in 2006 and is based in Seoul, South Korea. GENOLUTION is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with Genolution

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genolution position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genolution will appreciate offsetting losses from the drop in the long position's value.

Moving together with Genolution Stock

  0.69278650 KNOTUS CoLtdPairCorr
  0.72293780 AptaBio TherapeuticsPairCorr

Moving against Genolution Stock

  0.56105560 KB Financial GroupPairCorr
The ability to find closely correlated positions to Genolution could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genolution when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genolution - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genolution to buy it.
The correlation of Genolution is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genolution moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genolution moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genolution can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Genolution Stock

Genolution financial ratios help investors to determine whether Genolution Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genolution with respect to the benefits of owning Genolution security.